Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gonzalo Aizpurua
Institution:
Spanish National Cancer Research Centre
Observed institutions:
Consejo Superior de Investigaciones Científicas,
Spanish National Cancer Research Centre,
Centro Nacional de Biotecnología
ORCID:
0000-0002-4572-2272
Observed ORCID:
0000-0002-4572-2272
OpenAlex ID:
A5067700783
Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation
2022
·
Sara García-Alonso
, Pablo Mesa
, et al.
·
Molecular Cell
·
77
Helios Expression Is Downregulated on CD8+ Treg in Two Mouse Models of Lupus During Disease Progression
2022
·
Andrés París-Muñoz
, Gonzalo Aizpurua
, et al.
·
Frontiers in Immunology
·
9
The HSP90–CDC37 Chaperone System Orchestrates RAF1 Kinase Activation Through a Pre-Dimerization Mechanism
2026
·
Gonzalo Aizpurua
, Pablo Mesa
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1
2026
·
Laura de-la-Puente-Ovejero
, Ana Fernández-Rodríguez
, et al.
·
PLoS ONE
·
1
PDF
RAF1 scaffold integrity shapes chemogenetic degradation outcomes in KRAS-driven lung cancer models
2026
·
Laura de-la-Puente-Ovejero
, Ana Domostegui
, et al.
·
Life Science Alliance
PDF
Building insights into CDC37-RAF1 interaction: an opportunity for design new strategies to treat KRAS driven tumors.
2022
·
Experimental Oncology Group, Molecular Oncology Programme. Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain.
, Laura de la Puente Ovejero
, et al.
·
IBJ Plus
Show more works
View as search
Works count:
6
Citation count:
89
H-index:
2
I10-index:
1
Year
Topic
Type